Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Myocardial scintigraphy using cationic 99m Tc complexes].

R Dudczak, P Angelberger

    Nuklearmedizin. Nuclear Medicine
    |June 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Influence of PET reconstruction parameters on the TrueX algorithm. A combined phantom and patient study.

    Nuklearmedizin. Nuclear medicine·2013
    Same author

    Imaging of highly malignant osteosarcoma with iodine-123-vascular endothelial growth factor.

    Oncology·2012
    Same author

    Improved quality of life in patients treated with Peptide radionuclides.

    World journal of nuclear medicine·2011
    Same author

    Optimization of the radiosynthesis of the Alzheimer tracer 2-(4-N-[11C]methylaminophenyl)-6-hydroxybenzothiazole ([11C]PIB).

    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2011
    Same author

    Assessment of left ventricular volumes, ejection fraction and mass. Comparison of model-based analysis of ECG-gated (⁹⁹m)Tc-SPECT and ¹⁸F-FDG-PET.

    Nuklearmedizin. Nuclear medicine·2010
    Same author

    "Label and go"--a fast and easy radiolabelling method for pellets.

    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2009
    Same journal

    On the utility of ChatGPT in conducting a literature review on deep learning for dopamine transporter SPECT with [¹²³I]ioflupane.

    Nuklearmedizin. Nuclear medicine·2026
    Same journal

    McCune-Albright Syndrome with Extensive Fibrous Dysplasia Evaluated by 18F-FDG PET/CT and Whole-body Bone Scintigraphy: A Case Report.

    Nuklearmedizin. Nuclear medicine·2026
    Same journal

    False-Positive Rib Lesion on Bone Scintigraphy and 68Ga-PSMA PET/CT: Fibrous Dysplasia Mimicking Metastasis.

    Nuklearmedizin. Nuclear medicine·2026
    Same journal

    PSMA-exprimierende Nebennierenläsion beim Prostatakarzinom: Phäochromozytom statt Metastase.

    Nuklearmedizin. Nuclear medicine·2026
    Same journal

    A translational journey in Germany: From literature to local implementation of [89Zr]Zr-DFO-trastuzumab.

    Nuklearmedizin. Nuclear medicine·2026
    Same journal

    [68Ga]Ga-FAPI-04 PET/CT Delineates Peritoneal Carcinomatosis in Invasive Lobular Breast Cancer with Limited FDG Avidity.

    Nuklearmedizin. Nuclear medicine·2026
    See all related articles

    New technetium-99m (99mTc)-labeled tracers show promise for myocardial scintigraphy in assessing heart tissue. While not yet superior to thallium-201 (201Tl), these agents offer significant improvements for diagnosing coronary artery disease.

    Area of Science:

    • Nuclear medicine
    • Radiopharmacology
    • Cardiovascular imaging

    Background:

    • Myocardial scintigraphy is crucial for diagnosing coronary artery disease.
    • Technetium-99m (99mTc)-labeled agents are sought after for their favorable imaging characteristics.
    • Thallium-201 (201Tl) is the current standard but has limitations.

    Purpose of the Study:

    • To evaluate the efficacy of novel 99mTc-labeled cationic complexes for myocardial scintigraphy.
    • To compare the radiopharmacological properties and scintigraphic performance of 99mTc(III)-Cl2(DMPE)2 and 99mTc(I)-TBl.
    • To assess the potential of these agents in patients with coronary artery disease.

    Main Methods:

    • Radiopharmaceutical preparation and characterization of 99mTc(III)-Cl2(DMPE)2 and 99mTc(I)-TBl.

    Related Experiment Videos

  • In vivo scintigraphic imaging in patients with suspected or confirmed coronary artery disease.
  • Comparative analysis of image quality and diagnostic accuracy against 201Tl.

    • Main Results:

    • 99mTc-TBl demonstrated successful assessment of ischemic and infarcted myocardial tissue.
    • 99mTc-Cl2(DMPE)2 showed less favorable results compared to 99mTc-TBl.
    • Scintigraphic findings using 201Tl remained superior overall, but significant improvements were noted with the 99mTc agents.

    Conclusions:

    • 99mTc-TBl represents a promising advancement for myocardial imaging in coronary artery disease.
    • Further development of 99mTc-labeled tracers could lead to a clinically useful myocardial imaging agent.
    • The study highlights the ongoing progress towards improved non-invasive cardiac diagnostics using radiopharmaceuticals.